About Greer Laboratories
Greer Laboratories is a company based in Lenoir (United States) founded in 1998 was acquired by Waypoint Capital in March 2013. The company has 317 employees. Greer Laboratories offers products and services including Skin-testing extracts, AIT formulation services, and Allergenic extracts. Greer Laboratories operates in a competitive market with competitors including BeiGene, Serum Institute of India, BioNTech, Decibel Therapeutics and Vir Biotechnology, among others.
- Headquarter Lenoir, United States
- Employees 317
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website greerlabs.com
- Social LinkedIn
- Acquired by Waypoint Capital (Mar 2013)
- Legal Name Stallergenes Greer
- Investors
- Employee Count317
- Acquired byWaypoint Capital
(Mar 2013)
Products & Services of Greer Laboratories
Greer Laboratories offers a comprehensive portfolio of products and services, including Skin-testing extracts, AIT formulation services, and Allergenic extracts.
Products for diagnosing allergies via skin tests
Services for preparing allergy immunotherapy treatments
Extracts used in allergy immunotherapy for patients
Investors in Greer Laboratories
Greer Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B-FLEXION.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
B-FLEXION is recognized as a private entrepreneurial investment firm. | – | waypointcapital.net | - |
Investor details for Greer Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Greer Laboratories
2 dated milestones of Greer Laboratories across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Greer Laboratories is founded.
- Exit Acquired by Waypoint Capital.
Competitors of Greer Laboratories
Greer Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Serum Institute of India, BioNTech, Decibel Therapeutics and Vir Biotechnology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| seruminstitute.com | 1966 | Pune, India | – | 6,617 | Vaccines and immuno-biological drugs for infectious diseases are manufactured. | |
| biontech.com | 2008 | Mainz, Germany | $805.99M | 4,530 | Immunotherapeutics for cancer and other diseases are developed. | |
| decibeltx.com | 2015 | Cambridge, United States | $169.53M | 62 | Medicines are developed to protect, repair, and restore hearing capacity. | |
| vir.bio | 2017 | San Francisco, United States | $216M | 417 | Developer of therapeutics for the treatment of infectious diseases | |
| cidara.com | 2013 | San Diego, United States | $78.35M | 90 | Novel anti-infectives for bacterial and fungal infections are developed. | |
| sorrentotherapeutics.com | 1989 | San Diego, United States | – | 949 | Immuno therapeutics for cancer, inflammation, and autoimmune diseases are developed. | |
| anokion.com | 2010 | Ecublens, Switzerland | $112.5M | 30 | Therapeutic proteins are developed for autoimmune and allergic disease treatment. | |
| stallergenesgreer.com | 2013 | London, United Kingdom | – | 115,499 | Allergen immunotherapies for respiratory allergies are developed. |
Detailed competitors of Greer Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Greer Laboratories
Websites that share an audience with Greer Laboratories (greerlabs.com).
Websites whose visitors overlap most with Greer Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hauserpharmaceutical.com | 100% | 1.9K | #8,413,504 | View details | |
| endo.com | 100% | 10K | #2,323,439 | View details | |
| eisai.com | 100% | 74.5K | #534,857 | View details | |
| elan.com | 100% | – | – | View details | |
globalphar.com | globalphar.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Greer Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Greer Laboratories
10 companies that operate in the same segment as Greer Laboratories (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Greer Laboratories
Greer Laboratories was founded in 1998.
Greer Laboratories is headquartered in Lenoir, United States. It is registered at Lenoir, North Carolina, United States.
Greer Laboratories has 317 employees.
Greer Laboratories was established in 1998 in Lenoir, United States, within the pharmaceuticals sector focused on allergy treatments. Immunotherapy products for human and veterinary applications are produced by the company. Oralair, an allergen extract, is indicated for grass pollen-induced allergic rhinitis treatment. Greer extracts are utilized for analytical testing of total proteins, moisture, and specific allergens, supporting diagnostic and therapeutic needs in allergy care.
Greer Laboratories's top competitors include BeiGene, BioNTech and Decibel Therapeutics.
Greer Laboratories offers Skin-testing extracts, AIT formulation services, and Allergenic extracts.
Greer Laboratories has 1 investor. Key investors include B-FLEXION.
Greer Laboratories operates through Stallergenes Greer.
Yes. Greer Laboratories was acquired by Waypoint Capital in March 2013.